The Daily Biotech Pulse: Moderna Seeks FDA Approval For COVID-19 Shot For Children 2-6, Tax Disclosure For Amgen, Fast Track Tags For SQZ Biotech, Timber Pharma Candidates
Here's a roundup of top developments in the biotech space over the last 24 hours:
Cannabis Stock Gainers And Losers From April 22, 2022
GAINERS:
MariMed (OTC:MRMD) shares closed up 5.59% at $0.72
Cannabis Stock Movers For April 11, 2022
GAINERS:
Cann Gr (OTC:CNGGF) shares closed up 10.05% at $0.30
5 Cannabis Stocks Wall Street Analysts Rate Buy: No, Tilray Is Not Among Them
The cannabis industry blossomed during the pandemic, some say unexpect
Cannabis Stock Gainers And Losers From April 7, 2022
GAINERS:
Origin Agritech (NASDAQ:SEED) shares closed up 15.34% at $8.42
Cara Therapeutics Announces Biomarker Data From KALM-1 And KALM-2 Trials Of KORSUVA Injection Selected For Presentation At National Kidney Foundation Spring Clinical Meetings 2022
Cara Therapeutics, Inc. (NASDAQ:CARA), an early commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced biomarker data
Marijuana Stock Movers For April 1, 2022
GAINERS:
Cara Therapeutics (NASDAQ:CARA) shares closed up 4.28% at $12.67
12 Health Care Stocks Moving In Wednesday’s After-Market Session
Gainers
Greenwich LifeSciences (NASDAQ:GLSI) stock moved upwards by 9.6% to $23.84 during Wednesday's after-market session. The market value of their outstanding shares is at $312.8 million. As per the press release, Q4 earnings came out 2 days ago.